These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11585967)

  • 1. Thymidine phosphorylase (TP) activation: convenience through innovation.
    Van Cutsem E; Cunningham D; Hoff PM; Maroun J
    Oncologist; 2001; 6 Suppl 4():1-2. PubMed ID: 11585967
    [No Abstract]   [Full Text] [Related]  

  • 2. [Doxifluridine for treatment of colorectal cancer].
    Nishimura G; Miwa K
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():345-8. PubMed ID: 14574909
    [No Abstract]   [Full Text] [Related]  

  • 3. Thymidine phosphorylase (platelet-derived endothelial cell growth factor) as a target for capecitabine: from biology to the bedside.
    Ranieri G; Roccaro AM; Vacca A; Ribatti D
    Recent Pat Anticancer Drug Discov; 2006 Jun; 1(2):171-83. PubMed ID: 18221035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Making capecitabine targeted therapy for breast cancer: which is the role of thymidine phosphorylase?
    Bonotto M; Bozza C; Di Loreto C; Osa EO; Poletto E; Puglisi F
    Clin Breast Cancer; 2013 Jun; 13(3):167-72. PubMed ID: 23218471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of sensitivity to capecitabine in human renal carcinoma cells transfected with thymidine phosphorylase cDNA.
    Morita T; Matsuzaki A; Tokue A
    Int J Cancer; 2001 May; 92(3):451-6. PubMed ID: 11291085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymidine phosphorylase and dihydropyrimidine dehydrogenase levels in primary colorectal cancer show a relationship to clinical effects of 5'-deoxy-5-fluorouridine as adjuvant chemotherapy.
    Nishimura G; Terada I; Kobayashi T; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Kayahara M; Shimizu K; Ohta T; Miwa K
    Oncol Rep; 2002; 9(3):479-82. PubMed ID: 11956613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology and therapeutic efficacy of capecitabine: focus on breast and colorectal cancer.
    Aprile G; Mazzer M; Moroso S; Puglisi F
    Anticancer Drugs; 2009 Apr; 20(4):217-29. PubMed ID: 19247178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: up-regulation of thymidine phosphorylase.
    Saif MW; Black G; Roy S; Bell D; Russo S; Eloubeidi MA; Steg A; Johnson MR; Zelterman D; Diasio RB
    Cancer J; 2007; 13(4):247-56. PubMed ID: 17762760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capecitabine in advanced gastric or oesophagogastric cancer: a viewpoint by Sai-Hong Ignatius Ou and Randall F. Holcombe.
    Ou SH; Holcombe RF
    Drugs; 2007; 67(4):611-2. PubMed ID: 17352521
    [No Abstract]   [Full Text] [Related]  

  • 10. X-ACT: an important step on an unfinished journey.
    Maughan T
    Ann Oncol; 2012 Jul; 23(7):1655-8. PubMed ID: 22517823
    [No Abstract]   [Full Text] [Related]  

  • 11. Capecitabine: the new generation of fluoropyrimidines in colorectal cancer.
    Iqbal S; Lenz HJ
    Expert Rev Anticancer Ther; 2004 Dec; 4(6):947-55. PubMed ID: 15606325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of the effect of capecitabine in gastric cancer by immunohistochemical staining of thymidine phosphorylase and dihydropyrimidine dehydrogenase.
    Koizumi W; Okayasu I; Hyodo I; Sakamoto J; Kojima H;
    Anticancer Drugs; 2008 Sep; 19(8):819-24. PubMed ID: 18690094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymidine phosphorylase and capecitabine: a predictive marker for therapy selection?
    O'Neil BH; McLeod HL
    J Clin Oncol; 2006 Sep; 24(25):4051-3. PubMed ID: 16943521
    [No Abstract]   [Full Text] [Related]  

  • 14. [Capecitabine in the treatment of colorectal cancer].
    Zeuli M; Pino MS; Cognetti F
    Tumori; 2001; 87(1 Suppl 1):S55-6. PubMed ID: 11300027
    [No Abstract]   [Full Text] [Related]  

  • 15. Thymidine phosphorylase to dihydropyrimidine dehydrogenase ratio as a predictive factor of response to preoperative chemoradiation with capecitabine in patients with advanced rectal cancer.
    Boskos CS; Liacos C; Korkolis D; Aygerinos K; Lamproglou I; Terpos E; Stoupa E; Baltatzis G; Beroukas K; Papasavvas P; Dimopoulos MA; Bamias A
    J Surg Oncol; 2010 Oct; 102(5):408-12. PubMed ID: 19877119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capecitabine in the management of colorectal cancer.
    Maroun JA
    Expert Rev Anticancer Ther; 2001 Oct; 1(3):327-33. PubMed ID: 12113099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capecitabine in the treatment of colorectal cancer.
    Kelly C; Cassidy J
    Expert Rev Anticancer Ther; 2007 Jun; 7(6):803-10. PubMed ID: 17555390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival on capecitabine in two gemcitabine refractory pancreatic cancer patients. Is there a pharmacogenetic explanation?
    Saif MW; Kang SP; Ledbetter L; Steg A; Diasio R; Johnson M
    JOP; 2007 Nov; 8(6):799-805. PubMed ID: 17993734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The potential of capecitabine (Xeloda) in the treatment of disseminated solid tumors].
    Moiseenko VM; Semenova AI; Orlova RV
    Vopr Onkol; 2001; 47(1):112-9. PubMed ID: 11317529
    [No Abstract]   [Full Text] [Related]  

  • 20. Thymidine phosphorylase expression and effect of doxifluridine: a phase II study.
    Sadahiro S; Otani Y; Oya K; Ike H; Shimada H; Yamaguchi S; Hiki Y; Fujita H; Mitomi T
    Oncol Rep; 2001; 8(4):753-8. PubMed ID: 11410777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.